Medical technology company ImpediMed Limited (ASX:IPD) has secured the first commercial heart failure sales for its SOZO® Digital Health Platform. An initial five SOZO® units have been sold to Phoenix Healthcare Network, which operates cardio-pulmonary rehabilitation units within nursing homes and long-term care facilities.
SOZO® will be used in the management of heart failure patients. SOZO®’s HF-Dex™ assessment offers real-time information about fluid status that clinicians can use to manage medication levels and prevent readmission. According to Tom Jordan, CEO of Phoenix Healthcare Network, SOZO® will be at the center of patient monitoring.
ImpediMed’s shares traded at $0.12, up by over 14% in the early trading hours on 18 November 2020.